1
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
295,541
$69.6m11.15%
11.15%
Reduced Shares held: Q3 2021 101.8k, Q4 2021 164.3k, Q1 2022 305.9k, Q2 2022 295.5k
-10.3k
-10,309
-3.4%
2
THE BEAUTY HEALTH COMPANY
COM CL A
COM CL A
3,276,037
$42.1m6.75%
6.75%
Added Shares held: Q3 2021 202.0k, Q4 2021 0, Q1 2022 227.6k, Q2 2022 3.3m
+3.0m
+3,048,425
1339.3%
3
ORGANOGENESIS HLDGS INC
COM
ORGO
ORGO
5,286,167
$25.8m4.13%
4.13%
Added Shares held: Q3 2021 639.9k, Q4 2021 2.0m, Q1 2022 2.5m, Q2 2022 5.3m
+2.7m
+2,746,000
108.1%
4
SURMODICS INC
COM
SRDX
SRDX
661,004
$24.6m3.94%
3.94%
Added Shares held: Q3 2021 381.5k, Q4 2021 532.8k, Q1 2022 558.4k, Q2 2022 661.0k
+102.6k
+102,564
18.4%
5
EDAP TMS S A
SPONSORED ADR
FOCL
FOCL
3,284,189
$22.3m3.58%
3.58%
Added Shares held: Q3 2021 3.0m, Q4 2021 3.1m, Q1 2022 3.1m, Q2 2022 3.3m
+135.6k
+135,580
4.3%
6
IRADIMED CORP
COM
IRMD
IRMD
620,765
$21.1m3.37%
3.37%
Added Shares held: Q3 2021 450.7k, Q4 2021 450.0k, Q1 2022 430.1k, Q2 2022 620.8k
+190.7k
+190,714
44.4%
7
CVS HEALTH CORP
COM
CVS
CVS
219,400
$20.3m3.26%
3.26%
Added Shares held: Q3 2021 0, Q4 2021 138.0k, Q1 2022 92.5k, Q2 2022 219.4k
+126.9k
+126,900
137.2%
8
THERATECHNOLOGIES INC
COM
COM
7,822,412
$17.8m2.84%
2.84%
Added Shares held: Q3 2021 7.6m, Q4 2021 7.7m, Q1 2022 7.7m, Q2 2022 7.8m
+130.3k
+130,330
1.7%
9
ARCELLX INC
COMMON STOCK
ACLX
ACLX
909,739
$16.4m2.63%
2.63%
Reduced Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 989.7k, Q2 2022 909.7k
-80.0k
-80,000
-8.1%
10
INSPIRE MED SYS INC
COM
INSP
INSP
88,950
$16.2m2.60%
2.60%
Added Shares held: Q3 2021 30.9k, Q4 2021 27.4k, Q1 2022 47.9k, Q2 2022 89.0k
+41.0k
+41,050
85.7%
11
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
214,482
$14.1m2.26%
2.26%
Reduced Shares held: Q3 2021 125.5k, Q4 2021 228.4k, Q1 2022 289.3k, Q2 2022 214.5k
-74.9k
-74,855
-25.9%
12
ESSA PHARMA INC
COM NEW
EPI
EPI
4,168,799
$13.1m2.10%
2.10%
Reduced Shares held: Q3 2021 2.9m, Q4 2021 3.5m, Q1 2022 4.2m, Q2 2022 4.2m
-55.0k
-55,000
-1.3%
13
ANAPTYSBIO INC
COM
ANAB
ANAB
643,575
$13.1m2.09%
2.09%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 643.6k
14
ANGIODYNAMICS INC
COM
ANGO
ANGO
670,000
$13.0m2.08%
2.08%
Reduced Shares held: Q3 2021 242.5k, Q4 2021 515.5k, Q1 2022 1.0m, Q2 2022 670.0k
-356.4k
-356,450
-34.7%
15
DICE THERAPEUTICS INC
COM
COM
815,740
$12.7m2.03%
2.03%
Reduced Shares held: Q3 2021 879.9k, Q4 2021 810.9k, Q1 2022 984.0k, Q2 2022 815.7k
-168.3k
-168,254
-17.1%
16
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
994,492
$12.6m2.02%
2.02%
Reduced Shares held: Q3 2021 263.9k, Q4 2021 743.2k, Q1 2022 1.0m, Q2 2022 994.5k
-17.1k
-17,146
-1.7%
17
APOLLO ENDOSURGERY INC
COM
COM
3,268,948
$11.9m1.91%
1.91%
Added Shares held: Q3 2021 0, Q4 2021 2.3m, Q1 2022 2.9m, Q2 2022 3.3m
+375.8k
+375,848
13.0%
18
NEUROPACE INC
COM
NPCE
NPCE
2,334,003
$11.6m1.85%
1.85%
Added Shares held: Q3 2021 1.7m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
+10.0k
+10,000
0.4%
19
ASTRAZENECA PLC
SPONSORED ADR
SPONSORED ADR
169,696
$11.2m1.80%
1.80%
Added Shares held: Q3 2021 319.4k, Q4 2021 478.6k, Q1 2022 112.7k, Q2 2022 169.7k
+57.0k
+57,000
50.6%
20
TANDEM DIABETES CARE INC
COM NEW
TNDM
TNDM
183,800
$10.9m1.74%
1.74%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 183.8k
21
VIRIDIAN THERAPEUTICS INC
COM
VRDN
VRDN
841,018
$9.7m1.56%
1.56%
Added Shares held: Q3 2021 0, Q4 2021 90.0k, Q1 2022 90.0k, Q2 2022 841.0k
+751.0k
+751,018
834.5%
22
CUTERA INC
COM
CUTR
CUTR
257,600
$9.7m1.55%
1.55%
New Shares held: Q3 2021 14.5k, Q4 2021 86.2k, Q1 2022 0, Q2 2022 257.6k
23
EVOLUS INC
COM
EOLS
EOLS
810,676
$9.4m1.51%
1.51%
Reduced Shares held: Q3 2021 642.9k, Q4 2021 1.3m, Q1 2022 1.4m, Q2 2022 810.7k
-557.7k
-557,713
-40.8%
24
BIOATLA INC
COM
BCAB
BCAB
3,262,703
$9.3m1.49%
1.49%
Added Shares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 3.3m
+747.3k
+747,279
29.7%
25
IVERIC BIO INC
COM
OPHT
OPHT
914,346
$8.8m1.41%
1.41%
Reduced Shares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 964.5k, Q2 2022 914.3k
-50.1k
-50,130
-5.2%
26
PENUMBRA INC
COM
PEN
PEN
68,800
$8.6m1.37%
1.37%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 68.8k
27
VAXCYTE INC
COM
PCVX
PCVX
370,650
$8.1m1.29%
1.29%
Added Shares held: Q3 2021 355.6k, Q4 2021 294.8k, Q1 2022 328.4k, Q2 2022 370.6k
+42.3k
+42,300
12.9%
28
IOVANCE BIOTHERAPEUTICS INC
COM
IOVA
IOVA
719,600
$7.9m1.27%
1.27%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 719.6k
29
PIERIS PHARMACEUTICALS INC
COM
COM
4,134,868
$7.7m1.24%
1.24%
Unchanged Shares held: Q3 2021 740.0k, Q4 2021 687.4k, Q1 2022 4.1m, Q2 2022 4.1m
30
STERIS PLC
SHS USD
STE
STE
37,310
$7.7m1.23%
1.23%
Reduced Shares held: Q3 2021 0, Q4 2021 52.1k, Q1 2022 41.3k, Q2 2022 37.3k
-4.0k
-3,950
-9.6%
31
SUPERNUS PHARMACEUTICALS INC
COM
SUPN
SUPN
258,100
$7.5m1.20%
1.20%
Added Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 251.0k, Q2 2022 258.1k
+7.1k
+7,100
2.8%
32
CVRX INC
COM
CVRX
CVRX
1,059,040
$6.4m1.02%
1.02%
Added Shares held: Q3 2021 619.1k, Q4 2021 962.2k, Q1 2022 962.2k, Q2 2022 1.1m
+96.9k
+96,875
10.1%
33
HORIZON THERAPEUTICS PUB L
SHS
HZNP
HZNP
77,842
$6.2m0.99%
0.99%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 77.8k
34
INCYTE CORP
COM
INCY
INCY
79,700
$6.1m0.97%
0.97%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 79.7k
35
TRANSMEDICS GROUP INC
COM
TMDX
TMDX
184,455
$5.8m0.93%
0.93%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 184.5k
36
EIGER BIOPHARMACEUTICALS INC
COM
CLDN
CLDN
846,000
$5.3m0.85%
0.85%
Added Shares held: Q3 2021 213.5k, Q4 2021 0, Q1 2022 783.0k, Q2 2022 846.0k
+63.0k
+63,000
8.1%
37
STAAR SURGICAL CO
COM PAR $0.01
STAA
STAA
75,094
$5.3m0.85%
0.85%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 75.1k
38
INARI MED INC
COM
NARI
NARI
72,298
$4.9m0.79%
0.79%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 72.3k
39
FATE THERAPEUTICS INC
COM
FATE
FATE
194,400
$4.8m0.77%
0.77%
Reduced Shares held: Q3 2021 0, Q4 2021 7.8k, Q1 2022 205.9k, Q2 2022 194.4k
-11.5k
-11,500
-5.6%
40
ENANTA PHARMACEUTICALS INC
COM
ENTA
ENTA
100,000
$4.7m0.76%
0.76%
Reduced Shares held: Q3 2021 182.4k, Q4 2021 318.3k, Q1 2022 202.5k, Q2 2022 100.0k
-102.5k
-102,485
-50.6%
41
EXACT SCIENCES CORP
COM
EXAS
EXAS
119,000
$4.7m0.75%
0.75%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 119.0k
42
NATERA INC
COM
NTRA
NTRA
131,873
$4.7m0.75%
0.75%
Reduced Shares held: Q3 2021 139.0k, Q4 2021 227.6k, Q1 2022 155.0k, Q2 2022 131.9k
-23.1k
-23,127
-14.9%
43
ROCKET PHARMACEUTICALS INC
COM
RCKT
RCKT
318,100
$4.4m0.70%
0.70%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 318.1k
44
ESTABLISHMENT LABS HLDGS INC
COM
ESTA
ESTA
78,400
$4.3m0.68%
0.68%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 78.4k
45
INMODE LTD
SHS
INMD
INMD
187,449
$4.2m0.67%
0.67%
Added Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 146.5k, Q2 2022 187.4k
+40.9k
+40,949
27.9%
46
PLIANT THERAPEUTICS INC
COM
PLRX
PLRX
490,000
$3.9m0.63%
0.63%
Added Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 240.0k, Q2 2022 490.0k
+250.0k
+250,000
104.2%
47
CHEMOCENTRYX INC
COM
CCXI
CCXI
154,400
$3.8m0.61%
0.61%
New Shares held: Q3 2021 0, Q4 2021 68.3k, Q1 2022 0, Q2 2022 154.4k
48
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
196,018
$3.8m0.61%
0.61%
Reduced Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 343.5k, Q2 2022 196.0k
-147.5k
-147,482
-42.9%
49
CELCUITY INC
COM
CELC
CELC
418,912
$3.8m0.61%
0.61%
Added Shares held: Q3 2021 83.7k, Q4 2021 32.1k, Q1 2022 32.1k, Q2 2022 418.9k
+386.8k
+386,839
1206.1%
50
LANTHEUS HLDGS INC
COM
LNTH
LNTH
55,222
$3.6m0.58%
0.58%
Reduced Shares held: Q3 2021 1.2m, Q4 2021 1.8m, Q1 2022 178.4k, Q2 2022 55.2k
-123.2k
-123,205
-69.0%
51
DEXCOM INC
COM
DXCM
DXCM
47,236
$3.5m0.56%
0.56%
Added Shares held: Q3 2021 0, Q4 2021 31.0k, Q1 2022 46.4k, Q2 2022 47.2k
+800
+800
1.7%
52
LYRA THERAPEUTICS INC
COM
LYRA
LYRA
592,417
$3.3m0.54%
0.54%
New Shares held: Q3 2021 215.6k, Q4 2021 10.0k, Q1 2022 0, Q2 2022 592.4k
53
FIBROGEN INC
COM
COM
302,226
$3.2m0.51%
0.51%
Reduced Shares held: Q3 2021 0, Q4 2021 1.6m, Q1 2022 1.1m, Q2 2022 302.2k
-762.1k
-762,130
-71.6%
54
IO BIOTECH INC
COM
IOBTQ
IOBTQ
655,404
$3.1m0.49%
0.49%
Reduced Shares held: Q3 2021 0, Q4 2021 672.7k, Q1 2022 672.7k, Q2 2022 655.4k
-17.3k
-17,330
-2.6%
55
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
20,100
$2.9m0.47%
0.47%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 20.1k
56
XENON PHARMACEUTICALS INC
COM
XENE
XENE
75,000
$2.3m0.37%
0.37%
Reduced Shares held: Q3 2021 215.7k, Q4 2021 379.0k, Q1 2022 189.8k, Q2 2022 75.0k
-114.8k
-114,797
-60.5%
57
C4 THERAPEUTICS INC
COM STK
CCCC
CCCC
282,640
$2.1m0.34%
0.34%
Added Shares held: Q3 2021 750.6k, Q4 2021 561.1k, Q1 2022 166.7k, Q2 2022 282.6k
+115.9k
+115,904
69.5%
58
KEZAR LIFE SCIENCES INC
COM
COM
252,000
$2.1m0.33%
0.33%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 252.0k
59
Y-MABS THERAPEUTICS INC
COM
YMAB
YMAB
136,182
$2.1m0.33%
0.33%
Reduced Shares held: Q3 2021 265.7k, Q4 2021 310.5k, Q1 2022 239.0k, Q2 2022 136.2k
-102.8k
-102,800
-43.0%
60
VERASTEM INC
COM
COM
1,644,500
$1.9m0.31%
0.31%
Unchanged Shares held: Q3 2021 0, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
61
PEPGEN INC
COM
PEPG
PEPG
175,000
$1.7m0.28%
0.28%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 175.0k
62
CHINOOK THERAPEUTICS INC
COM
ADRO
ADRO
88,000
$1.5m0.25%
0.25%
New Shares held: Q3 2021 0, Q4 2021 298.7k, Q1 2022 0, Q2 2022 88.0k
63
CRISPR THERAPEUTICS AG
NAMEN AKT
CRSP
CRSP
22,000
$1.3m0.21%
0.21%
Unchanged Shares held: Q3 2021 92.2k, Q4 2021 22.0k, Q1 2022 22.0k, Q2 2022 22.0k
64
XILIO THERAPEUTICS INC
COM
COM
453,660
$1.3m0.21%
0.21%
Reduced Shares held: Q3 2021 0, Q4 2021 477.5k, Q1 2022 477.5k, Q2 2022 453.7k
-23.8k
-23,835
-5.0%
65
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
95,485
$1.2m0.20%
0.20%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 95.5k
66
BRIDGEBIO PHARMA INC
NOTE 2.500% 3/1 · principal
BBIO 2.5 03.15.27 · principal
BBIO 2.5 03.15.27
1,950,000
$1.1m0.17%
0.17%
Unchanged Principal held: Q3 2021 1.9m, Q4 2021 1.9m, Q1 2022 1.9m, Q2 2022 1.9m
67
OUTSET MED INC
COM
OM
OM
69,200
$1.0m0.16%
0.16%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 69.2k
68
NOVOCURE LTD
ORD SHS
NVCR
NVCR
13,275
$923.0k0.15%
0.15%
Reduced Shares held: Q3 2021 27.3k, Q4 2021 22.3k, Q1 2022 17.3k, Q2 2022 13.3k
-4.0k
-4,000
-23.1%
69
IMMUNIC INC
COM
COM
240,000
$833.0k0.13%
0.13%
Unchanged Shares held: Q3 2021 0, Q4 2021 175.0k, Q1 2022 240.0k, Q2 2022 240.0k
70
VISTAGEN THERAPEUTICS INC
COM NEW
VTGN
VTGN
825,000
$726.0k0.12%
0.12%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 825.0k
71
DA32 LIFE SCNCE TEC ACQSTN C
CLASS A COM
CLASS A COM
50,000
$485.0k0.08%
0.08%
Reduced Shares held: Q3 2021 350.0k, Q4 2021 350.0k, Q1 2022 100.0k, Q2 2022 50.0k
-50.0k
-50,000
-50.0%